Jolien F. Leijenaar

Lower cerebral blood flow in subjects with Alzheimer's dementia, mild cognitive impairment, and subjective cognitive decline using two‐dimensional phase‐contrast magnetic resonance imaging

Jolien F. Leijenaar, Ingrid S. van Maurik, Joost P.A. Kuijer et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2017 · 60 citations · Full text

Medicine, Neurology, Neuroscience +17

Performance of five automated white matter hyperintensity segmentation methods in a multicenter dataset

Rutger Heinen, Martijn D. Steenwijk, Frederik Barkhof et al. · Scientific Reports · 2019 · 57 citations · Full text

Medicine, Neurology, Radiology +17

Nemaline myopathy caused by <scp><i>TNNT1</i></scp> mutations in a <scp>D</scp>utch pedigree

W. Ludo van der Pol, Jolien F. Leijenaar, Wim G.M. Spliet et al. · Molecular Genetics & Genomic Medicine · 2013 · 50 citations · Full text

Medicine, Genetics, Neurology +14

Methylphenidate and galantamine in patients with vascular cognitive impairment–the proof-of-principle study STREAM-VCI

Jolien F. Leijenaar, Geert Jan Groeneveld, Erica S. Klaassen et al. · Alzheimer s Research & Therapy · 2020 · 25 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effect of magnesium treatment and glucose levels on delayed cerebral ischemia in patients with subarachnoid hemorrhage: a substudy of the Magnesium in Aneurysmal Subarachnoid Haemorrhage trial (MASH-II)

Jolien F. Leijenaar, Sanne M. Dorhout Mees, Ale Algra et al. · International Journal of Stroke · 2015 · 20 citations · Full text

Medicine, Neurological Surgery, Neurosurgery +13